Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04556435 · ClinicalTrials.gov registry record

Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy

A clinical trial, sponsored by Breathe BioMedical.

Terminated
Registry status
51
Enrollment target

NCT04556435: Clinical Trial study, sponsored by Breathe BioMedical.

NCT04556435 is a clinical trial that was terminated before completion, run by Breathe BioMedical. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04556435 was terminated before completion, sponsored by Breathe BioMedical.

TERMINATED
Registry status
51 participants
Enrollment target

Study Summary

The aim of this study is to sample and analyze volatile organic compounds (VOCs) from lung cancer patients and individuals without lung cancer ("healthy" controls). The breath sample analysis will help investigators describe and identify profiles of VOCs found in the breath of patients with lung cancer when compared to normal breath profiles using infrared spectroscopy. This work will help validate early proof of concept results conducted with prototype technology and later stage NSCLC breath samples, and inform future breath testing analysis.

Primary Outcome

VOC spectral profiles will be compared between cohorts to identify statistical differences.

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2021-02-25
Est. Completion 2023-08-04
Breathe BioMedical

3 total trials

Why NCT04556435 stopped before completion

NCT04556435 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT04556435 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04556435 about?

NCT04556435 is a clinical study titled "Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy". The aim of this study is to sample and analyze volatile organic compounds (VOCs) from lung cancer patients and individuals without lung cancer ("healthy" controls). The breath sample analysis will help investigators describe and identify profiles of VOCs found in the breath of patients with lung can...

What is the current status of trial NCT04556435?

This trial is currently terminated. The enrollment target is 51 participants. The study started on 2021-02-25. Estimated completion is 2023-08-04.

Who is sponsoring clinical trial NCT04556435?

This trial is sponsored by Breathe BioMedical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04556435, the US trial registry maintained by the National Library of Medicine. NCT04556435 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.